{
    "AKBM.OL": {
        "short_name": "AKER BIOMARINE AS",
        "long_name": "Aker BioMarine AS",
        "summary": "Aker BioMarine AS, a biotechnology company, develops krill-derived ingredients and products for nutraceutical, aquaculture, and animal feed applications. The company provides krill oil products, including omega-3s, phospholipids, choline, and astaxanthin for the human market under the Superba brand. It also offers Qrill aqua product for aquaculture; and QRILL pet, a functional ingredient for pet food. Aker BioMarine AS has an agreement with Medical Food Solutions Research to develop pharmaceutical therapies for brain and eye health. The company is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.",
        "currency": "NOK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "OSL",
        "market": "no_market",
        "country": "Norway",
        "city": "Lysaker"
    },
    "NATTO.OL": {
        "short_name": "NATTOPHARMA ASA",
        "long_name": "NattoPharma ASA",
        "summary": "NattoPharma ASA engages in the research and development of vitamin K2 for applications in the marketplace for nutritional supplements and enriched foods. The company's flagship brand is MenaQ7, a vitamin K2 for bone and cardiovascular health. It also provides marketing and sales support services. The company has a partnership agreement with KD Nutra to create a cardiovascular-support ingredient that combines KD Nutra's KD-P\u00c3\u00bcR high concentrate omega-3s with the company's MenaQ7 PharmaPure MK-7; and a research partnership with the University of Maastricht to lead the exploration of K2 discovery and its role in improving human health. NattoPharma ASA was founded in 2004 and is headquartered in Oslo, Norway.",
        "currency": "NOK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "OSL",
        "market": "no_market",
        "country": "Norway",
        "city": "Oslo"
    },
    "PHO.OL": {
        "short_name": "PHOTOCURE ASA",
        "long_name": "Photocure ASA",
        "summary": "Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.",
        "currency": "NOK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "OSL",
        "market": "no_market",
        "country": "Norway",
        "city": "Oslo"
    },
    "VISTN.OL": {
        "short_name": "VISTIN PHARMA ASA",
        "long_name": "Vistin Pharma ASA",
        "summary": "Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients worldwide. It offers metformin active pharmaceutical ingredients and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was incorporated in 2015 and is headquartered in Oslo, Norway.",
        "currency": "NOK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "OSL",
        "market": "no_market",
        "country": "Norway",
        "city": "Oslo"
    },
    "VP4.F": {
        "short_name": "VISTIN PHARMA ASA  NK 1",
        "long_name": "Vistin Pharma ASA",
        "summary": "Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients worldwide. It offers metformin active pharmaceutical ingredients and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was incorporated in 2015 and is headquartered in Oslo, Norway.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Norway",
        "city": "Oslo"
    }
}